Web Results

Board & Management :: Inspyr Therapeutics, Inc. (NSPX)

www.inspyrtx.com/team

Inspyr Therapeutics, Inc. Home · About ... Russell Richerson, PhD. COO. Russell B. ... Peter E. Grebow, PhD ... Bo Jesper Hansen, MD, PhD ... Scott V. Ogilvie.

Engineering a Prostate-Specific Membrane Antigen-Activated Tumor ...

content.stockpr.com/genspera/db/Publications/673/pdf/120627_SCI.pdf

Jun 27, 2012 ... Samuel R. Denmeade,1* Annastasiah M. Mhaka,1 D. Marc Rosen,1 ... George Wilding,3 Michael A. Carducci,1 Craig A. Dionne,4 Jesper V. Møller,2,5 Poul Nissen,2,6 ...... Purified G202 for animal studies was provided by GenSpera Inc. ... Milowsky et al. with a PSMA antibody (clone 3E6; Dako) diluted 1:20.

Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4984914/

Apr 26, 2016 ... ... (ECs) of a variety of solid tumours types (Liu et al, 1997; Chang et al, 1999a, ..... GenSpera, Inc. provided assistance with preparation of this manuscript. ... [ PubMed]; Deniaud A, Sharaf el dein O, Malillier E, Poncet D, Kroemer ... Gill DL, Isaacs JT (1994) The role of calcium, pH, and cell proliferation in the ...

Bruce N. Ames, Ph.D. - About Dr. Ames

www.bruceames.org/

The Laboratory of Bruce Ames, PhD ... Both of these V/M have built into metabolism a triage-like trade-off between short-term ... Damms-Machado A., et al.

Zachary Nye, Ph.D., M.Sc. - Stanford Consulting Group, Inc.

www.scginc.com/zacharynye;jsessionid=FftZdyLUhIcQNpo CGiN8DGo.8b08cb51-c10d-3c77-af72-b0079a40d4f7

Zachary Nye, Ph.D. is a Vice President and a financial economist at SCG. ... Partners, L.P. Derivative Litigation; City of Austin Police Retirement System et al. v.

More Info

GenSpera Announces Management Changes | Business Wire

www.businesswire.com

Mar 22, 2016 ... GenSpera, Inc. (OTC/QB: GNSZ), a biotech company developing a novel ... Peter E. Grebow Ph.D., a GenSpera Director, has been appointed ...

Engineering a Prostate-Specific Membrane Antigen–Activated ...

www.ncbi.nlm.nih.gov

Jun 27, 2012 ... 1, D and E). ..... Purified G202 for animal studies was provided by GenSpera Inc. PSMA ... of Milowsky et al. with a PSMA antibody (clone 3E6; Dako) diluted 1:20 in .... The role of calcium, pH, and cell proliferation in the programmed .... Singh P, Mhaka AM, Christensen SB, Gray JJ, Denmeade SR, Isaacs JT.

Zacks Small Cap Research - GNSZ: Mipsagargin Shows Clinical ...

scr.zacks.com

Nov 23, 2015 ... By David Bautz, PhD. OTC:GNSZ. Financial Update. On November 13, 2015, GenSpera, Inc. (OTC:GNSZ) filed form 10-Q with financial ... and systemic administration of thapsigargin is highly toxic (Denmeade et al., 1993). ..... V: Select Sands reports 1st Fiscal Quarter Results: Very Healthy Working Capital.